Ketoconazole Retains Activity in Advanced Prostate Cancer Patients with Progression Despite Flutamide Withdrawal-Reference-Cited by-同舟云学术

Ketoconazole Retains Activity in Advanced Prostate Cancer Patients with Progression Despite Flutamide Withdrawal

Published:1997-04 Issue:4 Volume:157 Page:1204-1207
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Small Eric J.¹,Baron Ari D.¹,Fippin Linda¹,Apodaca Dan¹

Affiliation:

1. From the Departments of Medicine, Urology and Nursing, and Urologic Oncology Program, University of California, San Francisco Cancer Center, San Francisco, California

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference20 articles.

1. Secondary hormonal manipulation;Smith,1996

2. Treatment of progressive metastatic prostate cancer;Dawson;Oncology,1993

3. Flutamide withdrawal syndrome: its impact on clinical trials in hormone-refractory prostate cancer;Scher;J. Clin. Oncol.,1993

4. The antiandrogen withdrawal syndrome. Experience in a large cohort of unselected patients with advanced prostate cancer;Small;Cancer,1995

5. Prostate specific antigen decline following the discontinuation of flutamide in patients with stage D2 prostate cancer;Figg;Amer. J. Med.,1995

Cited by 181 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival by first‐line therapy and prognostic group among men with metastatic castration‐resistant prostate cancer;Cancer Medicine;2024-06

2. The Efficacy of Ketoconazole Containing Regimens in Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis;Clinical Genitourinary Cancer;2024-04

3. Testosterone analysis in prostate cancer patients;Advances in Clinical Chemistry;2022

4. Ketoconazole;Androgenetic Alopecia From A to Z;2022

5. Androgen receptor signaling inhibitors: post-chemotherapy, pre-chemotherapy and now in castration-sensitive prostate cancer;Endocrine-Related Cancer;2021-08-01